| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
| filingDate |
1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c58b4a82bb751548c83d62bb95b9c17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34aaf99d10a784f820458211b7211b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc9d8753ad279d33dc569dcc034a2e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e439646e87ecf641e76d4a4d5181f3fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889e97a3f2f7e8448a583af11cbbcc92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95da571075241ee3cd474271470ff658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb6066a80eb74f7416d1ca90af8b100
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39574647daa4bf9a8da382519198284f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f84f5bef9a5de8bee644f287cd7464b |
| publicationDate |
1998-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19713001-A1 |
| titleOfInvention |
Gramina pollen allergen mutants for specific immunotherapy, their production and use |
| abstract |
The invention relates to modified recombinant allergen mutants which can be obtained from recombinant allergens derived from allergens obtained by means of extraction from natural raw materials, such as the pollen of the species Phelum pratense. These modified recombinant allergens stimulate the lymphocytes of persons suffering from a pollen allergy to bring about proliferation and cytokine synthesis, but have a significantly reduced capacity to bond with the IgE antibodies contained in the serum of lymphocyte donors and with grass pollen allergen specific IgEs. The inventive modified recombinant allergens can therefore be used for a specific, individual allergy treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004108758-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8628946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004245184-B2 |
| priorityDate |
1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |